Denise A. Valenti, OD, FAAO
Denise A. Valenti, OD, FAAO, is currently is owner of IMMAD-Impairment Measurement Marijuana and Driving. The company provided education, services and technology for the responsible use of cannabis. The current emphasis is on the technology IMMAD. IMMAD is a two minute objective test for law enforcement use to determine fitness to drive with marijuana consumption.
The science behind IMMAD is complex, but the test is simple. Dr. Denise A. Valenti is a residency-trained, low-vision/blind-rehabilitation optometrist with additional education and expertise in the field of age-related neurodegenerative diseases with the emphasis on Parkinson's disease and Alzheimer's disease.
Dr. Valenti has had additional training as an MGH/MIT/HMS Functional MRI Fellow at the Martinos Center for Biomedical Imaging in Boston, Massachusetts and participated in the yearlong seminar series offered through the Boston University Sleep Disorders Center Fellowship program.
Her research has included the study of imaging of retinal neural tissue using Optical Coherence Tomography and functional assessment of neural processing in the visual system using Frequency Doubling Technology. Dr. Valenti provided direct clinical care for more than 25 years and currently is active in research and consultation related to vision, aging, neuroprocessing and cognitive functions. Dr. Valenti has taught Low Vision and Geriatrics at the MCPHS University School of Optometry and Gerontology at Quincy College and provides medical content to numerous professional newsletters throughout the United States.
Meet the Winners of Ocular Disease Case Study Week: Denise A. Valenti, OD, FAAO
Meet the third-place winner in Ocular Disease Case Study Week. Learn more about what Denise A. Valenti, OD, FAAO, discovered about how marijuana impacts retinal ganglion cells.